Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2017, Article ID 3518402, 5 pages
https://doi.org/10.1155/2017/3518402
Research Article

Efficacy and Safety of Manual Partial Red Cell Exchange in the Management of Severe Complications of Sickle Cell Disease in a Developing Country

1Hematology, Cheikh Anta Diop University, BP 5005, Dakar, Senegal
2Centre National de Transfusion Sanguine, BP 5002, Dakar, Senegal

Correspondence should be addressed to B. F. Faye; rf.oohay@eyafxilefesialb

Received 13 November 2016; Revised 24 February 2017; Accepted 11 April 2017; Published 11 May 2017

Academic Editor: Angela Panoskaltsis-Mortari

Copyright © 2017 B. F. Faye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. T. Chou, “Transfusion therapy for sickle cell disease : a balancing act.,” Hematology. American Society of Hematology. Education Program, pp. 439–446, 2013. View at Google Scholar
  2. P. S. Swerdlow, “Red cell exchange in sickle cell disease,” Hematology. American Society of Hematology. Education Program, pp. 48–53, 2006. View at Google Scholar
  3. D. A. Tsitsikas, B. Sirigireddy, R. Nzouakou et al., “Safety, tolerability, and outcomes of regular automated red cell exchange transfusion in the management of sickle cell disease,” Journal of Clinical Apheresis, vol. 31, no. 6, pp. 545–550, 2016. View at Google Scholar
  4. R. E. Ware and R. W. Helms, “Stroke with transfusions changing to hydroxyurea (SWITCH),” Blood, vol. 119, no. 17, pp. 3925–3932, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Ware, B. R. Davis, W. H. Schultz et al., “Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH) : a multicentre, open-label, phase 3, non-inferiority trial,” The Lancet, vol. 387, pp. 661–670, 2016. View at Google Scholar
  6. B. P. Yawn, G. R. Buchanan, A. N. Afenyi-Annan et al., “Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members,” JAMA, vol. 312, no. 10, pp. 1033–1048, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. S. Dzik, D. Kyeyune, G. Otekat et al., “Transfusion medicine in sub-saharan Africa: conference summary,” Transfusion Medicine Reviews, vol. 29, no. 3, pp. 195–204, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. C. Kim, “Red cell exchange: Special focus on sickle cell disease,” Hematology. American Society of Hematology. Education Program, vol. 2014, no. 1, pp. 450–456, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. De Montalembert, “Échanges érythrocytaires chez les patients drépanocytaires,” Hématologie, vol. 13, pp. 243–249, 2007. View at Google Scholar
  10. K. H. M. Kuo, R. Ward, B. Kaya, J. Howard, and P. Telfer, “A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients,” British journal of haematology, vol. 170, no. 3, pp. 425–428, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Koehl, J. Sommet, L. Holvoet et al., “Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia,” Transfusion, vol. 56, no. 5, pp. 1121–1128, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Dokekias and G. B. Basseila, “Résultats des échanges transfusionnels partiels chez 42 patients drépanocytaires homozygotes au CHU de Brazzaville,” Transfusion Clinique et Biologique, vol. 17, pp. 232–241, 2010. View at Google Scholar
  13. H. S. Mian, R. Ward, P. Telfer, B. Kaya, and K. H. M. Kuo, “Optimal manual exchange transfusion protocol for sickle cell disease: a retrospective comparison of two comprehensive care centers in the United Kingdom And Canada,” Hemoglobin, vol. 39, no. 5, pp. 310–315, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. T. Chou and R. M. Fasano, “Management of patients with sickle cell disease using transfusion therapy: guidelines and complications,” Hematology/Oncology Clinics of North America, vol. 30, no. 3, pp. 591–608, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. C. P. Minniti, J. Eckman, P. Sebastiani, M. H. Steinberg, and S. K. Ballas, “Leg ulcers in sickle cell disease,” American Journal of Hematology, vol. 85, no. 10, pp. 831–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. J. Kato, “Priapism in sickle-cell disease: a hematologist's perspective,” The Journal of Sexual Medicine, vol. 9, no. 1, pp. 70–78, 2012. View at Publisher · View at Google Scholar
  17. S. K. Ballas and D. Lyon, “Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease,” Journal of Clinical Apheresis, vol. 31, no. 1, pp. 5–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. M. N. Aloni, M. N. Aloni, P.-Q. Lê et al., “A pilot study of manual chronic partial exchange transfusion in children with sickle disease,” Hematology, vol. 20, no. 5, pp. 284–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-J. Lefrère, H. Dahourouh, A. E. Dokekias et al., “Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study,” Transfusion, vol. 51, no. 3, pp. 486–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Seck, B. Dièye, Y. B. Guèye, B. F. Faye, A. B. Senghor, and S. A. Toure, “Évaluation de l’efficacité de la sélection médicale des donneurs de sang dans la prévention des agents infectieux,” Transfusion Clinique et Biologique, vol. 23, pp. 98–102, 2016. View at Google Scholar
  21. A. O. Touré-Fall, T. N. Dièye, A. Sall, M. Diop, M. Seck, and S. Diop, “Risque résiduel de transmission du VIH et du VHB par transfusion sanguine entre 2003 et 2005 au Centre national de transfusion sanguine de Dakar (Sénégal),” Transfusion Clinique et Biologique, vol. 16, pp. 439–443, 2009. View at Google Scholar
  22. T. N. Williams, “Sickle cell disease in Sub-Saharan Africa,” Hematology/Oncology Clinics of North America, vol. 30, no. 2, pp. 343–358, 2016. View at Publisher · View at Google Scholar
  23. S. Diop, S. O. Mokono, M. Ndiaye, A. O. Touré Fall, D. Thiam, and L. Diakhaté, “La drépanocytose homozygote après l'âge de 20 ans: suivi d'une cohorte de 108 patients au CHU de Dakar,” La Revue de Médecine Interne, vol. 24, pp. 711–715, 2003. View at Google Scholar
  24. A. Diarra, A. Guindo, B. Kouriba et al., “Sécurité transfusionnelle et drépanocytose à Bamako, Mali. Séroprévalence des infections à VIH, VHB, VHC et allo-immunisation anti-Rh et Kell chez les drépanocytaires,” Transfusion Clinique et Biologique, vol. 20, pp. 476–481, 2013. View at Google Scholar
  25. A. M. Ngoma, P. B. Mutombo, K. Ikeda, K. E. Nollet, B. Natukunda, and H. Ohto, “Red blood cell alloimmunization in transfused patients in sub-Saharan Africa: a systematic review and meta-analysis,” Transfusion and Apheresis Science, vol. 54, no. 2, pp. 296–302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-M. Michot, F. Driss, C. Guitton et al., “Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease,” Transfusion, vol. 55, no. 2, pp. 357–363, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Venkateswaran, J. Teruya, C. Bustillos, D. Mahoney, and B. U. Mueller, “Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease,” Pediatric Blood and Cancer, vol. 57, no. 2, pp. 294–296, 2011. View at Publisher · View at Google Scholar · View at Scopus